Published on Web 03/28/2007
Substrate Flexibility of Vicenisaminyltransferase VinC
Involved in the Biosynthesis of Vicenistatin
Atsushi Minami† and Tadashi Eguchi*,‡
Contribution from the Department of Chemistry, and Department of Chemistry and Materials
Science, Tokyo Institute of Technology, 2-12-1, O-okayama, Meguro-ku, Tokyo 152-8551, Japan
Received November 28, 2006; E-mail: eguchi@cms.titech.ac.jp
Abstract: A glycosyltransferase VinC is involved in the biosynthesis of antitumor â-glycoside antibiotic
vicenistatin. It catalyzes a glycosyl transfer reaction between dTDP-R-D-vicenisamine and vicenilactam.
Previous identification of its broad substrate specificity toward various glycosyl acceptors enabled us to
explore the potential of VinC for glycodiversification. In vitro study of the substrate specificity toward several
dTDP-sugars with vicenilactam established that VinC displayed activities with R-anomers of several dTDP-
2-deoxy-D-sugars such as mycarose, digitoxose, olivose, and 2-deoxyglucose to afford respective
â-glycosides. Notably, â-anomers of dTDP-2-deoxy-D-sugars also appeared to be accepted by VinC to
form R-glycosides. Furthermore, VinC is capable of catalyzing glycosyl transfer reactions from both the
R-anomer and â-anomer of dTDP-L-mycarose, respectively, into â-glycoside and R-glycoside. These results
indicate that VinC is a unique glycosyltransferase possessing broad substrate specificity. The mechanism
of this axially oriented glycosidic bond formation from the equatorially oriented dTDP-sugar might be
explained by conformational change of dTDP-sugar to a boat conformation during the glycosyl transfer
reaction. To apply these features of VinC for glycodiversification, 22 sets of structurally diverse glycosides
were constructed using unnatural glycosyl donors and acceptors.
Introduction
natural glycosides, further identification of new glycosyltrans-
ferases exhibiting a broad substrate specificity toward both sugar
Glycosyltransferase, which catalyzes a transfer of sugar in
the form of nucleoside diphosphosugar (NDP-sugar) to the
respective aglycons, is an important enzyme in the biosynthesis
of biologically active secondary metabolites because the pres-
ence of sugar is, in most cases, necessary for exerting their
biological activities.1 It is therefore a current subject of active
research in the field to exploit the usefulness of these glyco-
syltransferases for structurally diverse glycoside synthesis. In
fact, chemoenzymatic glycoside syntheses using glycosyltrans-
ferases have been applied to change the sugar fraction of natural
glycosides.2-7 Structural changes of the sugar component in
these examples include substitution of the functional group and
configurational change. In addition, recent studies have shown
examples of change in the aglycon part of natural glycosides
using glycosyltransferases.6-11 Although these examples indicate
the importance of a chemoenzymatic approach to create un-
and aglycon components is highly desirable for development
of a glycoside library because the success of this approach
depends mainly on the substrate specificity of glycosyltrans-
ferases themselves.
Vicenistatin (1), an antitumor â-glycosidic antibiotic produced
by Streptomyces halstedii HC 34, comprises amino sugar
vicenisamine and 20-membered macrocyclic vicenilactam (Fig-
ure 1A).12 We identified the whole vicenistatin biosynthetic gene
cluster (Vin) and confirmed that VinC is a vicenisaminyltrans-
ferase catalyzing the transfer of vicenisamine from dTDP-
vicenisamine (4) to vicenilactam (3) in the last step of
vicenistatin biosynthesis (Figure 1B).13 We recently demon-
strated that VinC accepts structurally diverse aglycons to form
respective vicenisaminides.9,11 The broad substrate specificity
toward the glycosyl acceptor showed that VinC is an attractive
glycosyltransferase for glycodiversification. On the other hand,
the substrate specificity of VinC toward a glycosyl donor
remains unclear, even though previous isolation of vicenistatin
M (2) indicated the possibility of D-mycarose transfer to
† Department of Chemistry.
‡ Department of Chemistry and Materials Science.
(1) Weymouth-Wilson, A. C. Nat. Prod. Rep. 1997, 14, 99.
(2) Griffith, B. R.; Langenhan, J. M.; Thorson, J. S. Curr. Opin. Biotechnol.
2005, 16, 622.
(3) Losey, H. C.; Jiang, J.; Biggins, J. B.; Oberthu¨r, M.; Ye, X.-Y.; Dong, S.
D.; Kahne, D.; Thorson, J. S.; Walsh, C. T. Chem. Biol. 2002, 9, 1305.
(4) Lu, W.; Leimkuhler, C.; Oberthu¨r, M.; Kahne, D.; Walsh, C. T. Biochem-
istry 2004, 43, 4548.
(5) Oberthu¨r, M.; Leimkuhler, C.; Kruger, R. G.; Lu, W.; Walsh, C. T.; Kahne,
D. J. Am. Chem. Soc. 2005, 127, 10747.
(6) Borisova, S. A.; Zhang, C.; Takahashi, H.; Zhang, H.; Wong, A. W.;
Thorson, J. S.; Liu, H.-W. Angew. Chem., Int. Ed. 2006, 45, 2748.
(7) Zhang, C.; Griffith, B. R.; Fu, Q.; Albermann, C.; Fu, X.; Lee, I.-K.; Li,
L.; Thorson, J. S. Science 2006, 313, 1291.
(8) Feel Meyers, C. L.; Oberthu¨r, M.; Anderson, J. W.; Kahne, D.; Walsh, C.
T. Biochemistry 2003, 42, 4179.
(9) Minami, A.; Uchida, R.; Eguchi, T.; Kakinuma, K. J. Am. Chem. Soc. 2005,
127, 6148.
(10) Yang, M.; Proctor, M. R.; Bolam, D. N.; Errey, J. C.; Field, R. A.; Gilbert,
H. J.; Davis, B. G. J. Am. Chem. Soc. 2005, 127, 9336.
(11) Minami, A.; Kakinuma, K.; Eguchi, T. Tetrahedron Lett. 2005, 46,
6187.
(12) Shindo, K.; Kamishohara, M.; Okagawa, A.; Matsuoka, M.; Kawai, H. J.
Antibiot. 1993, 46, 1076.
(13) Ogasawara, Y.; Katayama, K.; Minami, A.; Otsuka, M.; Eguchi, T.;
Kakinuma, K. Chem. Biol. 2004, 11, 79.
9
5102
J. AM. CHEM. SOC. 2007, 129, 5102-5107
10.1021/ja0685250 CCC: $37.00 © 2007 American Chemical Society